Annual Drug Patent Expirations for ARMONAIR+RESPICLICK Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are nineteen…
The post New patent expiration for Teva Pharm drug ARMONAIR R…
New patent expiration for Teva Pharm drug ARMONAIR RESPICLICK Read Post »
Annual Drug Patent Expirations for DIOVAN Diovan is a drug marketed by Novartis and is included in three NDAs. It is available from ten suppliers. There are two patents protecting…
The post New patent expiration for Novartis drug DIOVAN appeared …
Annual Drug Patent Expirations for AIRDUO+RESPICLICK Airduo Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from three suppliers. There are twenty-one…
The post New patent expiration for Teva Pharm drug AIRDUO RE…
New patent expiration for Teva Pharm drug AIRDUO RESPICLICK Read Post »
Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Teva Branded drug PROAIR RESPI…
New patent expiration for Teva Branded drug PROAIR RESPICLICK Read Post »
Annual Drug Patent Expirations for QVAR+REDIHALER Qvar Redihaler is a drug marketed by Norton Waterford and is included in one NDA. There are four patents protecting this drug. This drug…
The post New patent expiration for Norton Waterford drug Q…
New patent expiration for Norton Waterford drug QVAR REDIHALER Read Post »
QVAR 80 (beclomethasone dipropionate) Teva branded pharm Patent: 6,446,627 Expiration: Dec 18, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug Patent …
Drug Patent Expirations for the Week of December 17, 2017 Read Post »
Consumer access to effective and affordable medicines is an imperative for public health, social equity, and economic development, but this need is not being served adequately by the biopharmaceutical sector,…
The post Making Medicines Affordable…
Making Medicines Affordable: A National Imperative Read Post »
Contrary to popular belief, there are many unapproved drugs which are actively being used. Many physicians may not even realize that that the drugs they are prescribing have not been…
The post Unapproved Drugs: Opportunities for Rapid Approval an…
Unapproved Drugs: Opportunities for Rapid Approval and Market Exclusivity Read Post »
Changes in the pharmaceutical sales model have forced leaders to invest in new selling strategies in recent years. However most of these New Commercial Models (NCMs) have not produced enough…
The post Strategies for Pharmaceutical Companies to Bo…
Strategies for Pharmaceutical Companies to Boost Their Exports Read Post »
This article was originally published by Himanshu Gupta, Suresh Kumar, Saroj Kumar Roy, and R. S. Gaud at J Pharm Bioallied Sci. 2010 Jan-Mar; 2(1): 2–7. Abstract It is widely recognized…
The post Patent Protection Strategies appeared first on Dr…
Get new actionable insights and updates from BiotechBlog
